Astro-Med Aktie
WKN: 922775 / ISIN: US04638F1084
05.06.2025 15:00:27
|
AstroNova Slips To Loss In Q1, Ad. EBITDA, Orders Climb, Backs FY26 Outlook; Stock Up In Pre-market
(RTTNews) - AstroNova, Inc. (ALOT), a data visualization technology company, reported Thursday a loss in its first quarter, compared to prior year's profit. Adjusted EBITDA, a key earnings metric, climbed from last year, with strong growth in revenues. Orders also were higher, and the firm maintained its fiscal 2026 outlook.
In the pre-market activity on the Nasdaq, AstroNova shares were gaining around 7.5 percent to trade at $9.80
The latest results included MTEX following its acquisition on May 6, which has been fully integrated into the Product Identification segment.
In the first quarter, net loss was $0.38 million or a loss of $0.05 per share, compared with net income of $1.18 million or $0.15 per share last year.
Adjusted net income was $0.35 million or $0.05 per share. There were no adjustments in the prior-year period.
Adjusted EBITDA of $3.15 million increased 27.6 percent from last year's $2.47 million. Adjusted EBITDA margin expanded 80 basis points year-over-year 8.3 percent.
Revenue grew 14.4 percent to $37.71 million from last year's $32.96 million.
Orders in the first quarter were $34.9 million, up from $33.1 million in 2025. The Company's order backlog was $25.5 million as of April 30, compared with $28.3 million at the end of fiscal 2025.
Looking ahead, for fiscal 2026, AstroNova continues to expect net revenue in the range of $160 million to $165 million, which is a 7 percent increase over fiscal 2025 at the mid-point of the range.
Adjusted EBITDA margin is expected to be in the range of 8.5 percent to 9.5 percent, an 80-basis point expansion over the prior year at the mid-point.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Astro-Med Inc.mehr Nachrichten
Analysen zu Astro-Med Inc.mehr Analysen
Aktien in diesem Artikel
Astro-Med Inc. | 9,55 | 1,60% |
|